Report overview
For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.
This report aims to provide a comprehensive presentation of the global market for Cancer Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biopsy. This report contains market size and forecasts of Cancer Biopsy in global, including the following market information:
Global Cancer Biopsy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Biopsy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tissue Biopsies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Biopsy include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher and Lucence Diagnostics Pte. Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Biopsy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biopsy Market Segment Percentages, by Type, 2022 (%)
Tissue Biopsies
Liquid Biopsies
Others
Global Cancer Biopsy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biopsy Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Global Cancer Biopsy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Biopsy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Biopsy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Biopsy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qiagen N.V.
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Biocept, Inc.
Thermo Fisher Scientific, Inc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biopsy, market overview.
Chapter 2: Global Cancer Biopsy market size in revenue.
Chapter 3: Detailed analysis of Cancer Biopsy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biopsy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
